Brain-derived neurotrophic factor: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Line 7: Line 7:


==Notable studies ==
==Notable studies ==
*2015, Exercise and caffeine improve sustained attention following fatigue independent of fitness status<ref name="Kumar2015">https://www.tandfonline.com/doi/abs/10.1080/21641846.2015.1027553</ref> - [https://web.archive.org/web/20190225113231id_/http://pdfs.semanticscholar.org/61f9/b87e28a4902e1cc01250fca88dd39221256f.pdf (Full text)]
*2015, Exercise and caffeine improve sustained attention following fatigue independent of fitness status<ref name="Kumar2015">{{Cite journal|title=Exercise and caffeine improve sustained attention following fatigue independent of fitness status|date=2015-04-03|url=https://doi.org/10.1080/21641846.2015.1027553|journal=Fatigue: Biomedicine, Health & Behavior|volume=3|issue=2|pages=104–121|last=Kumar|first=Namrita|last2=Wheaton|first2=Lewis A.|last3=Snow|first3=Teresa K.|last4=Millard-Stafford|first4=Melinda|doi=10.1080/21641846.2015.1027553|issn=2164-1846}}</ref> - [https://web.archive.org/web/20190225113231id_/http://pdfs.semanticscholar.org/61f9/b87e28a4902e1cc01250fca88dd39221256f.pdf (Full text)]
*2015, Brain-derived neurotrophic factor (BDNF) as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?<ref name="Nijs2015">{{Cite journal|title=Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?|date=Apr 2015|url=https://pubmed.ncbi.nlm.nih.gov/25519921/|journal=Expert Opinion on Therapeutic Targets|volume=19|issue=4|pages=565–576|last=Nijs|first=Jo|author-link=Jo Nijs|last2=Meeus|first2=Mira|author-link2=Mira Meeus|last3=Versijpt|first3=Jan|author-link3=|last4=Moens|first4=Maarten|author-link4=|last5=Bos|first5=Inge|author-link5=|last6=Knaepen|first6=Kristel|author-link6=|last7=Meeusen|first7=Romain|doi=10.1517/14728222.2014.994506|pmc=|pmid=25519921|access-date=|issn=1744-7631|quote=|via=}}</ref> - [http://www.ncbi.nlm.nih.gov/pubmed/25519921 (Full text)]
*2015, Brain-derived neurotrophic factor (BDNF) as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?<ref name="Nijs2015">{{Cite journal|title=Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?|date=Apr 2015|url=https://pubmed.ncbi.nlm.nih.gov/25519921/|journal=Expert Opinion on Therapeutic Targets|volume=19|issue=4|pages=565–576|last=Nijs|first=Jo|author-link=Jo Nijs|last2=Meeus|first2=Mira|author-link2=Mira Meeus|last3=Versijpt|first3=Jan|author-link3=|last4=Moens|first4=Maarten|author-link4=|last5=Bos|first5=Inge|author-link5=|last6=Knaepen|first6=Kristel|author-link6=|last7=Meeusen|first7=Romain|doi=10.1517/14728222.2014.994506|pmc=|pmid=25519921|access-date=|issn=1744-7631|quote=|via=}}</ref> - [http://www.ncbi.nlm.nih.gov/pubmed/25519921 (Full text)]
*2020, DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia<ref name="Polli2020">{{Cite journal|last=Polli|first=Andrea|author-link=Andrea Polli|last2=Ghosh|first2=Manosij|author-link2=|last3=Bakusic|first3=Jelena|author-link3=|last4=Ickmans|first4=Kelly|author-link4=Kelly Ickmans|last5=Monteyne|first5=Dora|author-link5=|last6=Velkeniers|first6=Brigitte|author-link6=|last7=Bekaert|first7=Bram|last8=Godderis|first8=Lode|author-link8=Godderis Lode|last9=Nijs|first9=Jo|author-link9=Jo Nijs|date=Nov 2020|title=DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia|url=https://pubmed.ncbi.nlm.nih.gov/32562379/|journal=Arthritis & Rheumatology (Hoboken, N.J.)|volume=72|issue=11|pages=1936–1944|doi=10.1002/art.41405|issn=2326-5205|pmc=|pmid=32562379|access-date=|quote=|via=}}</ref> - [https://pubmed.ncbi.nlm.nih.gov/32562379/ (Abstract)]
*2020, DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia<ref name="Polli2020">{{Cite journal|last=Polli|first=Andrea|author-link=Andrea Polli|last2=Ghosh|first2=Manosij|author-link2=|last3=Bakusic|first3=Jelena|author-link3=|last4=Ickmans|first4=Kelly|author-link4=Kelly Ickmans|last5=Monteyne|first5=Dora|author-link5=|last6=Velkeniers|first6=Brigitte|author-link6=|last7=Bekaert|first7=Bram|last8=Godderis|first8=Lode|author-link8=Godderis Lode|last9=Nijs|first9=Jo|author-link9=Jo Nijs|date=Nov 2020|title=DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia|url=https://pubmed.ncbi.nlm.nih.gov/32562379/|journal=Arthritis & Rheumatology (Hoboken, N.J.)|volume=72|issue=11|pages=1936–1944|doi=10.1002/art.41405|issn=2326-5205|pmc=|pmid=32562379|access-date=|quote=|via=}}</ref> - [https://pubmed.ncbi.nlm.nih.gov/32562379/ (Abstract)]

Revision as of 21:59, January 16, 2022

Brain-derived neurotrophic factor or BDNF is a protein in the neurotrophic family.[1] The name BDNF is also used to refer to the related gene that expresses BDNF.[1]

Function[edit | edit source]

ME/CFS[edit | edit source]

Notable studies[edit | edit source]

  • 2015, Exercise and caffeine improve sustained attention following fatigue independent of fitness status[2] - (Full text)
  • 2015, Brain-derived neurotrophic factor (BDNF) as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?[3] - (Full text)
  • 2020, DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia[4] - (Abstract)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 Binder, Devin K.; Scharfman, Helen E. (September 2004). "Brain-derived Neurotrophic Factor". Growth factors (Chur, Switzerland). 22 (3): 123–131. doi:10.1080/08977190410001723308. ISSN 0897-7194. PMC 2504526. PMID 15518235.
  2. Kumar, Namrita; Wheaton, Lewis A.; Snow, Teresa K.; Millard-Stafford, Melinda (April 3, 2015). "Exercise and caffeine improve sustained attention following fatigue independent of fitness status". Fatigue: Biomedicine, Health & Behavior. 3 (2): 104–121. doi:10.1080/21641846.2015.1027553. ISSN 2164-1846.
  3. Nijs, Jo; Meeus, Mira; Versijpt, Jan; Moens, Maarten; Bos, Inge; Knaepen, Kristel; Meeusen, Romain (April 2015). "Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?". Expert Opinion on Therapeutic Targets. 19 (4): 565–576. doi:10.1517/14728222.2014.994506. ISSN 1744-7631. PMID 25519921.
  4. Polli, Andrea; Ghosh, Manosij; Bakusic, Jelena; Ickmans, Kelly; Monteyne, Dora; Velkeniers, Brigitte; Bekaert, Bram; Godderis, Lode; Nijs, Jo (November 2020). "DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia". Arthritis & Rheumatology (Hoboken, N.J.). 72 (11): 1936–1944. doi:10.1002/art.41405. ISSN 2326-5205. PMID 32562379.